New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - clotrimazole 500mg (micronised); clotrimazole 10 mg/g - combination - active: clotrimazole 500mg (micronised) excipient: gelatin glycerol liquid paraffin purified water quinoline yellow sunset yellow fcf titanium dioxide white soft paraffin active: clotrimazole 10 mg/g excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate octyldodecanol polysorbate 60 purified water sorbitan stearate - canesten clotrimazole thrush treatment once pessary + cream is indicated for the topical treatment of vulvovaginal candidiasis. the cream can also be used in the management of candida vulvovaginitis or infection of the peri-anal area, while application of the cream to the glans penis of the partner may help prevent re-infection of the female.

United States - English - NLM (National Library of Medicine)

unit dose services - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole 10 mg in 1 g - clotrimazole and betamethasone dipropionate cream is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum , trichophyton mentagrophytes , and trichophyton rubrum in patients 17 years and older. none. teratogenic effects, pregnancy category c there are no adequate and well-controlled studies with clotrimazole and betamethasone dipropionate cream in pregnant women. therefore, clotrimazole and betamethasone dipropionate cream should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. there have been no teratogenic studies performed in animals or humans with the combination of clotrimazole and betamethasone dipropionate. corticosteroids are generally teratogenic in laboratory animals when administered at relatively low dosage levels. studies in pregnant rats with intravaginal doses up to 100 mg/kg (15 times the maximu

New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - clotrimazole 500mg (micronised) - pessary - 500 mg - active: clotrimazole 500mg (micronised) excipient: calcium lactate, hydrate as pentahydrate colloidal silicon dioxide crospovidone hypromellose lactic acid lactose monohydrate magnesium stearate maize starch microcrystalline cellulose - canesten clotrimazole thrush 1 day pessary and 6 day vaginal pessaries are indicated for the topical treatment of vaginal candidiasis.

New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - clotrimazole 100mg (micronised) - pessary - 100 mg - active: clotrimazole 100mg (micronised) excipient: calcium lactate, hydrate colloidal silicon dioxide crospovidone hypromellose lactic acid lactose monohydrate magnesium stearate maize starch microcrystalline cellulose - canesten clotrimazole thrush treatment once and 6 day vaginal pessaries are indicated for the topical treatment of vaginal candidiasis.

United States - English - NLM (National Library of Medicine)

roxane - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - lozenge - clotrimazole troches (clotrimazole lozenges) are indicated for the local treatment of oropharyngeal candidiasis. the diagnosis should be confirmed by a koh smear and/or culture prior to treatment. clotrimazole troches (clotrimazole lozenges) are also indicated prophylactically to reduce the incidence of oropharyngeal candidiasis in patients immunocompromised by conditions that include chemotherapy, radiotherapy, or steroid therapy utilized in the treatment of leukemia, solid tumors, or renal transplantation. there are no data from adequate and well-controlled trials to establish the safety and efficacy of this product for prophylactic use in patients immunocompromised by etiologies other than those listed in the previous sentence. (see dosage and administration.) clotrimazole troches (clotrimazole lozenges) are contraindicated in patients who are hypersensitive to any of its components. no data available.

United States - English - NLM (National Library of Medicine)

stat rx usa - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole 10 mg - clotrimazole and betamethasone dipropionate cream is indicated in patients 17 years and older for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris and tinea corporis due to epidermophyton floccosum , trichophyton mentagrophytes , and trichophyton rubrum . effective treatment without the risks associated with topical corticosteroid use may be obtained using a topical antifungal agent that does not contain a corticosteroid, especially for noninflammatory tinea infections. the efficacy of clotrimazole and betamethasone dipropionate cream for the treatment of infections caused by zoophilic dermatophytes (e.g., microsporum canis ) has not been established. several cases of treatment failure of clotrimazole and betamethasone dipropionate cream in the treatment of infections caused by microsporum canis have been reported. clotrimazole and betamethasone dipropionate cream is contraindicated in patients who are sensitive to clotrimazole, betamethasone dipropionate, other cortic

New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - clotrimazole 500mg (micronised) - pessary - 500 mg - active: clotrimazole 500mg (micronised) excipient: gelatin glycerol liquid paraffin purified water quinoline yellow sunset yellow fcf titanium dioxide white soft paraffin - canesten clotrimazole thrush treatment once and 6 day vaginal pessaries are indicated for the topical treatment of vaginal candidiasis.

United States - English - NLM (National Library of Medicine)

direct rx - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole and betamethasone dipropionate cream is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum, trichophyton mentagrophytes, and trichophyton rubrum in patients 17 years and older. none. 8.1 pregnancy risk summary there are no available data on topical betamethasone dipropionate or clotrimazole use in pregnant women to identify clotrimazole and betamethasone dipropionate cream associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. observational studies suggest an increased risk of low birthweight infants with the use of potent or very potent topical corticosteroid during pregnancy. advise pregnant women that clotrimazole and betamethasone dipropionate cream may increase the risk of having a low birthweight infant and to use clotrimazole and betamethasone dipropionate cream on the smallest area of skin and for the

Canada - English - Health Canada

taro pharmaceuticals inc - clotrimazole - cream - 1% - clotrimazole 1% - azoles

Canada - English - Health Canada

taro pharmaceuticals inc - clotrimazole - cream - 2% - clotrimazole 2% - azoles